ImmunityBio, Inc.IBRXNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P42
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -12.80% |
| 2024 | 30.21% |
| 2023 | 26.20% |
| 2022 | -24.06% |
| 2021 | 89.65% |
| 2020 | 687.78% |
| 2019 | -74.47% |
| 2018 | -34.11% |
| 2017 | -42.98% |
| 2016 | -58.27% |